Family of Gibco High-Intensity Perfusion CHO Medium
What's new—Gibco Efficient-Pro Medium & Feeds help enhance CHO cell protein quality and productivity

Gibco Efficient-Pro Medium and Gibco Efficient-Pro Feeds 1 and 2 help deliver superior product performance, improved product titer, better protein quality and lot-to-lot consistency, which provides more control and predictability. Each medium is chemically defined, completely scalable and available as Gibco Advanced Granulation Technology (AGT) formats for sustained cell viability. The AGT dry media format enables a simple and scalable reconstitution process. These formats help maximize process efficiency with simplified preparation. Customers with larger-scale operations will benefit from longer bioreactor runs, reduced risk in reconstitution and flexibility to support these CHO cell lines.

Gibco Efficient-Pro Medium in liquid and Advanced Granulation Technology (AGT) formats

Gibco Efficient-Pro™ Medium

  • Tested in, and pairs best with feeds for, CHO-S, CHO-K1, and CHO-DG44
  • Together cell-specific Efficient-Pro Feeds, helps increase titer and cell viability
Gibco Efficient-Pro Feeds 1/ Gibco Efficient-Pro Feeds 1in liquid and Advanced Granulation Technology (AGT) formats

Gibco Efficient-Pro™ Feed 1

  • Tested in, and pairs best with feeds for CHO-K1
  • Together with Efficient-Pro Medium, helps increase titer and cell viability
Gibco Efficient-Pro Feeds 1/ Gibco Efficient-Pro Feeds 1in liquid and Advanced Granulation Technology (AGT) formats

Gibco Efficient-Pro™ Feed 2

  • Tested in, and pairs best with feeds CHO-S and DG44
  • Together with Efficient-Pro Medium, helps increase titer and cell viability

CHO cells cultured in Efficient-Pro media demonstrated improved protein production—High titers established across CHO variants and vessel size show increased end-product yield, viable cell density, reduced batch numbers, and lower cost with CHO-K1 and CHO-S cells.

Glycan and charge variant profiles—Improved protein quality established across all CHO variants creating increased end-product yield, reduced purification steps, and improved efficacy in CHO-K1 and CHO-S cells.

High specific productivity of IgG across nearly all CHO variants and vessel size demonstrates opportunity for improved yield, enhanced protein production, and extended harvest stage in CHO-K1, CHO-S, and DG-44 cells.

CHO-K1 cell growth

Efficient-Pro Medium and Efficient-Pro Feed 1 maintained high viability and lower cell density indicating a higher specific productivity compared to the competitor.

CHO-S cell productivity

Compared to the alternative medium and feeds, Efficient-Pro Medium and Feed 2 with CHO-S cells realized with a 144% relative average titer by day 14 and up to 180% relative average specific productivity (qP).

DG-44 cell productivity

Compared to the alternative medium and feeds, Efficient-Pro Medium and Feed 2 with DG44 cells showed a 312% relative average titer by day 14 with up to a 160% relative average specific productivity (qP).

CHO cells cultured in Efficient-Pro media demonstrated improved protein production—High titers established across CHO variants and vessel size show increased end-product yield, viable cell density, reduced batch numbers, and lower cost with CHO-K1 and CHO-S cells.

Glycan and charge variant profiles—Improved protein quality established across all CHO variants creating increased end-product yield, reduced purification steps, and improved efficacy in CHO-K1 and CHO-S cells.

High specific productivity of IgG across nearly all CHO variants and vessel size demonstrates opportunity for improved yield, enhanced protein production, and extended harvest stage in CHO-K1, CHO-S, and DG-44 cells.

CHO-K1 cell growth

Efficient-Pro Medium and Efficient-Pro Feed 1 maintained high viability and lower cell density indicating a higher specific productivity compared to the competitor.

CHO-S cell productivity

Compared to the alternative medium and feeds, Efficient-Pro Medium and Feed 2 with CHO-S cells realized with a 144% relative average titer by day 14 and up to 180% relative average specific productivity (qP).

DG-44 cell productivity

Compared to the alternative medium and feeds, Efficient-Pro Medium and Feed 2 with DG44 cells showed a 312% relative average titer by day 14 with up to a 160% relative average specific productivity (qP).

Learn more about AGT dry media formats and their advantages

Learn more about available media formats designed to support optimal CHO cell culture

High-Intensity Perfusion CHO Medium

Gibco High-Intensity Perfusion (HIP) CHO Medium can be used at multiple concentrations to support your process from seed train to production.

Just as it can be used at multiple concentrations, it can be used in multiple perfusion processes: N-1 and seed train, intensified fed-batch, concentrated fed batch, and continuous perfusion. Numerous CHO cell lines (CHO-S, CHO-DG44, CHO-GS, CHO-K1) have been tested in these perfusion processes with HIP CHO Medium.

In addition, the medium supports high cell densities at low medium exchange rates, which improves process efficiency, as low as 1 vessel volume/day (VVD).

Learn more about HIP CHO ›

Key features of HIP CHO Medium

Features

Benefits

Advanced granulated technology (AGT) format

Easy to use

Works with numerous CHO clones

CHO-S, CHO-GS, CHO-K1, CHO-DG44

Works in a variety of processes

Intensified fed-batch, concentrated fed batch, N-1, and continuous perfusion

Supports high cell densities at low medium exchange rates

Improved process efficiency

Supports multiple reconstituted concentrations

Product can be flexibly reconstituted to meet process needs

Gibco ExpiCHO SPMGibco ExpiCHO SMP

Gibco ExpiCHO SPM eliminates guesswork needed to find compatible media and feeds for scale-up. Simply transition your ExpiCHO-S cells after stable transfection for the same high titer and virtually none of the optimization.

  • Seamless transition
  • Confidence in performance
  • Risk reduction

Ideal with:

Cells

ExpiCHO-S

Feeds

EfficientFeed C+

Protein Quality

GlycanTune Total Feeds

Request a sample ›

Learn more about the ExpiCHO family ›

ExpiCHO family includes

  • ExpiCHO expression system for transient expression
  • ExpiCHO-S cells
  • ExpiCHO SPM

All products are designed to work seamlessly with one another easing the transition to stable expression helping you to commercialization faster.

Provides you with:

  • ONE solution—no media optimization required
  • Hassle-free scale-up—stable clone development protocol available

Learn more about the ExpiCHO family ›

expicho-family

The ExpiCHO SPM formulation is optimized for the ExpiCHO-S cells and outperforms other CHO medium on the market.

Figure 1 illustrates a comparative analysis. Stable clones were developed using the ExpiCHO stable clone development protocol and then transitioned to test media for an Ambr15 run. The highest output was achieved by ExpiCHO SPM, with the liquid and AGT (dry) formats performing comparably. The data represents 16 replicates for each format of ExpiCHO SPM and 3 replicates each for ActiPro and Advanced CHO respectively.

High-Intensity Perfusion CHO Medium

Gibco High-Intensity Perfusion (HIP) CHO Medium can be used at multiple concentrations to support your process from seed train to production.

Just as it can be used at multiple concentrations, it can be used in multiple perfusion processes: N-1 and seed train, intensified fed-batch, concentrated fed batch, and continuous perfusion. Numerous CHO cell lines (CHO-S, CHO-DG44, CHO-GS, CHO-K1) have been tested in these perfusion processes with HIP CHO Medium.

In addition, the medium supports high cell densities at low medium exchange rates, which improves process efficiency, as low as 1 vessel volume/day (VVD).

Learn more about HIP CHO ›

Key features of HIP CHO Medium

Features

Benefits

Advanced granulated technology (AGT) format

Easy to use

Works with numerous CHO clones

CHO-S, CHO-GS, CHO-K1, CHO-DG44

Works in a variety of processes

Intensified fed-batch, concentrated fed batch, N-1, and continuous perfusion

Supports high cell densities at low medium exchange rates

Improved process efficiency

Supports multiple reconstituted concentrations

Product can be flexibly reconstituted to meet process needs

Gibco ExpiCHO SPMGibco ExpiCHO SMP

Gibco ExpiCHO SPM eliminates guesswork needed to find compatible media and feeds for scale-up. Simply transition your ExpiCHO-S cells after stable transfection for the same high titer and virtually none of the optimization.

  • Seamless transition
  • Confidence in performance
  • Risk reduction

Ideal with:

Cells

ExpiCHO-S

Feeds

EfficientFeed C+

Protein Quality

GlycanTune Total Feeds

Request a sample ›

Learn more about the ExpiCHO family ›

ExpiCHO family includes

  • ExpiCHO expression system for transient expression
  • ExpiCHO-S cells
  • ExpiCHO SPM

All products are designed to work seamlessly with one another easing the transition to stable expression helping you to commercialization faster.

Provides you with:

  • ONE solution—no media optimization required
  • Hassle-free scale-up—stable clone development protocol available

Learn more about the ExpiCHO family ›

expicho-family

The ExpiCHO SPM formulation is optimized for the ExpiCHO-S cells and outperforms other CHO medium on the market.

Figure 1 illustrates a comparative analysis. Stable clones were developed using the ExpiCHO stable clone development protocol and then transitioned to test media for an Ambr15 run. The highest output was achieved by ExpiCHO SPM, with the liquid and AGT (dry) formats performing comparably. The data represents 16 replicates for each format of ExpiCHO SPM and 3 replicates each for ActiPro and Advanced CHO respectively.

Gibco media and feed selections by cell line

This table provides information on the most likely candidate based on a specific cell line. As all clones are unique, other media may in fact work more ideally and it is suggested to try a variety of media to test.

For more information on considerations when selecting the optimal match, go to our next section.

CHO cell typeGibco media optionMatched feed optionDoes medium contain growth factor? (Y/N)Is adaption necessary? (Y/N)
CHO-S

Efficient-Pro Medium

Efficient-Pro Feed 2

N

Y

 

CHO Medium

Difco TC Yeastolate UF

Y

Y

 

Dynamis Medium

EfficientFeed C+

N

Y

ExpiCHO-S

ExpiCHO SPM w/gf add back

EfficientFeed C+

Y

Y

 

ExpiCHO SPM

EfficientFeed C+

N

N

DG44/DXB11

Efficient-Pro Medium

Efficient-Pro Feed 2

N

Y

 

CHO Medium

OneFeed Supplement

Y

Y

 

Dynamis or CD OptiCHO Medium

EfficientFeed C+ or EfficientFeed A+

N

N

CHO-K1

Efficient-Pro Medium

Efficient-Pro Feed 1

N

Y

 

Dynamis Medium

EfficientFeed C+

N

Y

GS CHO

CD-1000 Medium

Resurge CD5 Supplement

Y

Y

 

Dynamis or CD CHO

EfficientFeed C+ or EfficientFeed B+

N

Y

Other CHO

CHO Medium

Difco TC Yeastolate UF

Y

Y

 

Dynamis or CD CHO Medium

EfficientFeed B+ or EfficientFeed C+

N

Y

*Drug Master File (DMF) information may be available and can be found at Drug Master Files (DMFs) and Regulatory Support Files (RSFs).

Find your optimal match with Gibco cell culture media

There are several pathways to find the right media or media and feed solution for CHO cell cultures. These pathways include selecting a standard or off-the-shelf media, our CHO media test panel, or a media development or optimization service. In order to find the right path, we need to remove the biggest obstacle; luck.

Often time, your goals on what you want to accomplish will narrow down the best selections for you.

Questions to consider:

  • What are you hoping to accomplish?
  • Do you know your timeline?
  • What is most critical?

Comparison of the different options available

 

Standard catalog media

Media test panel

Development or optimization service

Definition

Standard catalog products include our off-the-shelf CHO media, feed and supplement options.

Developed media panels with diverse formulations offering improved specificity, without the need for a full media development service.

Service solutions are provided by our Gibco BioProduction Services team, offering cell line development, media development, media optimization, process optimization, consultations, prototyping, format conversions and more.

Time

Fast

Relative speed

Dependent on scope; >3 months

Budget

Economical

Mostly cost-effective

More investment needed

Titer

Average to meets requirements

Meets requirements

Meets or surpasses requirements

Benefits

Quick turn-around

Standard media are available off-the-shelf.

Easy scale-up

Liquid and dry formats available that provide performance consistency and may reduce workflow steps to simplify your process.

Risk mitigation and assurance of supply

May be produced at either of our harmonized manufacturing locations.

Available data

Frequently, used in application notes and further testing.

Capacity

Secondary sourcing options; easy scale-up

More specificity

Options that are more specific to your clone and molecule.

Relative speed

Speed is important but not as much as matching product quality.

Regulatory support

For the panels, provides regularity support needed to succeed in getting approvals.

Resources and/or expertise

Need to outsource or consultation on your process

Secondary sourcing

Increase capacity of your own media and mitigate risk

Scale-up solutions

Transitioning from a liquid to a dry format during scale-up or performance support during scale-up or tech transfer

Improved performance

Optimal solution that delivers on your performance criteria

Platform media

Options that work better than current platform for multiple molecules

Regulatory support

We offer royalty-free CHO cell lines and documentation for regulatory filings.

Frequently, cell line specific component dependencies, like insulin and other growth factors, are missed when evaluating media. These are components that are needed for your cell line to thrive (growth, productivity) and if they are not present in the tested media, you may miss out on the optimal solution.

Matching media to your cell line should include an evaluation of whether these dependencies are in the media of choice or not (Tables 1 and 2) to determine whether you need to add them in or not.

Even with the cell line dependency component, in most cases, adaptation is required to see optimal results.

Additional components may also need to be considered for an optimal outcome (Table 3).

Questions:

  • Do you know if your cell line has any dependencies?
  • Are you planning on adapting the cells to the media?
  • Are other considerations necessary for the best result?
 

Standard catalog media

Media test panel

Development or optimization service

Dependencies

Table 1 lists media containing growth factors

Table 2 lists media without growth factors

Our media test panel does not contain typical cell line dependencies by default and can be added in as requested.

Our service offerings will evaluate these factors and other factors as specified.

Considerations

Additional components may be necessary for optimal performance (Table 3).


Table 1. Products that contain a growth factor, by cell line.

Cell type

Media option

Matched feed option

CHO-S

CHO Medium

Difco TC Yeastolate UF

ExpiCHO-S

ExpiCHO SPM* w/gf add back

EfficientFeed C+

DG44/DXB11

NutriCHO CD Medium* EX, LX, MAX

OneFeed Supplement

GS CHO

CD-1000 Medium

Resurge CD5 Supplement

Other CHO

CHO Medium

Difco TC Yeastolate UF

ALL

Development or optimization Services and Media Test Panel

Based on specifications

* No cell adaptation required

Table 2. Products that do not contain a growth factor, by cell line.

Cell type

Media option

Matched feed option

CHO-S

Dynamis Medium

EfficientFeed C+ Supplement

ExpiCHO-S

ExpiCHO SPM*

EfficientFeed C+ Supplement

DG44/DXB11

CD OptiCHO Medium*

EfficientFeed A+ Supplement

CHO-K1

Dynamis Medium

EfficientFeed C+ Supplement

GS CHO

Dynamis Medium

CD CHO Medium

EfficientFeed C+ Supplement

EfficientFeed B+ Supplement

Other CHO

Dynamis Medium

EfficientFeed C+ Supplement

All

Development and optimization services and Media Test Panel

Based on specifications

* No cell adaptation required

Table 3. Troubleshooting components to bundle with your medium selection.

 Situation

Recommendation

Cell Line cloned in medium containing insulin

Insulin and/or Long R3 IGF

Cell line is clumping

Titrate Anti-Clumping Agent starting at 1%

Cell line is sensitive to ammonia

GlutaMAX Supplement

Cell line is not sensitive to ammonia

Glutamine 

Performance drops (productivity, apoptosis), especially during scaling up

Peptones

Need to adjust the glycosylation profile

GlycanTune A+, B+ or C+ Total Feeds or GlycanMod Pak

Not all CHO clones are alike; each clone has a different metabolic baseline. When determining a new medium for your clone, you may want to consider a variety of available medium on the market to test. All options are scalable from small- to large-scale in a variety of formats.

 

Standard catalog media

Media test panel

Development or optimization service

Options

Order samples based on the below groupings for a diverse panel:

No growth factors in medium

  • Dynamis
  • CD CHO
  • CD OptiCHO
  • ExpiCHO SPM

Containing growth factors in medium

  • CHO Medium
  • CD-1000 Medium
  • NutriCHO CD

Order ›

Panel consists of five diverse chemically defined media which can be mixed to produce 21 test conditions

  • Completion of several design of experiments with panel formulations
  • Formulations can be easily supplemented upon request
  • Flexibility to perform experiments at your facility or ours

Learn more ›

In partnership with you, this service will provide solutions that are specific to your requirements.

Learn more ›



CHO media—ordering information

The flexibility of Gibco CHO media and feeds give you options to pair with most industry utilized cell lines, and are available in both catalog and customized options in multiple formats to suit your application needs:  

  • Faster growth
  • Highest performing titers
  • Sustained viable cell density
  • Chemically defined, serum-free, protein-free, and animal origin-free (AOF)
  • Flexible formats: liquid and AGT
  • Options to customize for every medium

Related products and services

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration in to humans or animals.